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Since the 1930s the birth incidence of Neural Tube defects
has been declining worldwide. The birth incidence varies
across time and in different geographic areas at the same
time.
The birth incidence is much lower than the prevalence
detected during the first trimester in both spontaneous
and elective terminations. Peaks of birth incidence have
been labelled "epidemics". These reports include varying
types of cases; some report only "Spina Bifida", whereas
others include two or more types of neural tube defects.
Several well-designed prospective studies have demon-
strated an impressive reduction in the occurrence or recur-
rence of myelomeningocele and anencephaly following
administration of folic acid beginning peri-conceptually.
The birth incidence is much lower than the prevalence
detected during the first trimester in both spontaneous
and elective terminations (Roberts and Lowe, 1975,
Creasy and Alberman, 1976; Nishimura, 1970). Chromo-
some anomalies are detected in up to 15% of early abor-
tuses or by amniocentesis but less than 1% of live born
patients with myelomeningocele (Luthy, 1991). The effect
of folic acid fortification in North America has been
reported in three epidemiological studies to be followed
by a 45 to 55% reduction. The data from our clinic
includes 440 births from 1981–2003 in Seattle and dem-
onstrates an 80% reduction in the birth incidence of Mye-
lomeningocele beginning in 1981–2000 from 0.4/1000
to 0.08/1000, a five-fold decrease. With the introduction
of folic acid fortification there was an increase to 0.16/
1000 in 2002, a two-fold increase. In 2003 the birth inci-
dence fell to 0.08 again. Conclusion: Our data demon-
strate the effects of intrauterine diagnosis and selective
termination prior to fortification of foodstuffs with folic
acid. Studies of the effect of folic acid fortification on the
birth incidence of Spina Bifida Occulta in communities
with a low incidence and active prenatal diagnosis and ter-
mination of affected foetuses require longer term studies
than published to date.
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